SHIME type study (University of Ghent) on the new microcapsules Intelicaps.
Thanks to Intelicaps, the protection of microorganisms during gastric passage is multiplied by 100 to 1000.
An in vitro SHIME study (dynamic scientific model reproducing the digestive system) tested the viability of probiotics (strains of Bifidobacterium lactis and Lactobacillus rhamnosus) through the gastric passage. Five reactors reproducing the environmental conditions of the stomach and small intestine at different stages were analysed independently. The concentration of bacteria was compared in lyophilized forms or in microcapsules Intelicaps®… This one concludes to a viability of 100 to 1000 times higher in the case of microcapsules.
Vésale Pharma has already introduced two products with Intelicaps technology on the Belgian market: Bacilac Forte and Bacilac Immunitum